RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 83 filers reported holding RELMADA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $56,198,000 | +30.4% | 1,518,056 | -33.1% | 8.67% | +2.1% |
| Q2 2022 | $43,109,000 | -29.6% | 2,270,072 | 0.0% | 8.49% | -14.5% |
| Q1 2022 | $61,269,000 | +19.8% | 2,270,072 | 0.0% | 9.93% | +42.0% |
| Q4 2021 | $51,145,000 | +40.6% | 2,270,072 | +63.6% | 6.99% | +49.6% |
| Q3 2021 | $36,372,000 | -18.1% | 1,387,720 | 0.0% | 4.67% | -13.3% |
| Q2 2021 | $44,421,000 | +47.9% | 1,387,720 | +62.6% | 5.39% | +65.3% |
| Q1 2021 | $30,041,000 | +40.1% | 853,206 | +27.6% | 3.26% | +3.4% |
| Q4 2020 | $21,437,000 | -14.8% | 668,440 | 0.0% | 3.15% | -35.9% |
| Q3 2020 | $25,147,000 | -15.9% | 668,440 | 0.0% | 4.92% | -31.3% |
| Q2 2020 | $29,913,000 | +4.1% | 668,440 | -20.7% | 7.16% | -8.0% |
| Q1 2020 | $28,748,000 | – | 842,814 | – | 7.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |